Sign in

CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
651311552
Phone
858.875.1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
  1. 4 Open-market sale President and CEO sold 60,000 shares at an average $100.67 ($6,039,968)
  2. 4 Grant or award Chief Development Officer acquired 18,013 shares (grant or award)
  3. 4 Grant or award General Counsel and Secretary acquired 18,013 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 14,411 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 18,013 shares (grant or award)
  6. 4 Open-market sale General Counsel and Secretary sold 35,000 shares at an average $114.76 ($4,016,639)
  7. 4 Open-market sale President and CEO sold 69,407 shares at an average $116.33 ($8,073,772)
  8. 4 Open-market sale Chief Development Officer sold 9,484 shares at an average $114.95 ($1,090,140)
  9. 4 Open-market sale General Counsel and Secretary sold 9,483 shares at an average $114.94 ($1,090,021)
  10. 4 Open-market sale Chief Scientific Officer sold 9,482 shares at an average $114.95 ($1,089,911)
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 21 · 403 filings